BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33844424)

  • 1. Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program.
    Hascoët S; Pontailler M; Le Pavec J; Savale L; Mercier O; Fabre D; Mussot S; Simonneau G; Jais X; Feuillet S; Stephan F; Cohen S; Bonnet D; Humbert M; Dartevelle P; Fadel E
    Am J Transplant; 2021 Oct; 21(10):3388-3400. PubMed ID: 33844424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France.
    Le Pavec J; Feuillet S; Mercier O; Pauline P; Dauriat G; Crutu A; Florea V; Savale L; Levy M; Laverdure F; Stephan F; Fabre D; Delphine M; Boulate D; Mussot S; Hascoët S; Bonnet D; Humbert M; Fadel E
    J Heart Lung Transplant; 2021 Jul; 40(7):652-661. PubMed ID: 33849770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era.
    Schaffer JM; Singh SK; Joyce DL; Reitz BA; Robbins RC; Zamanian RT; Mallidi HR
    Circulation; 2013 Jun; 127(25):2503-13. PubMed ID: 23697910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension.
    Savale L; Le Pavec J; Mercier O; Mussot S; Jaïs X; Fabre D; O'Connell C; Montani D; Stephan F; Sitbon O; Simonneau G; Dartevelle P; Humbert M; Fadel E
    Ann Thorac Surg; 2017 Aug; 104(2):404-411. PubMed ID: 28527964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the 2016 revision of US Pediatric Heart Allocation Policy on waitlist characteristics and outcomes.
    Magnetta DA; Godown J; West S; Zinn M; Rose-Felker K; Miller S; Feingold B
    Am J Transplant; 2019 Dec; 19(12):3276-3283. PubMed ID: 31544351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the new UNOS donor heart allocation system on waitlist outcomes and early posttransplant mortality among adults with congenital heart disease.
    Bravo-Jaimes K; Axsom K; Menachem J; Danford D; Kutty S; Cedars A
    Am J Transplant; 2022 Apr; 22(4):1123-1132. PubMed ID: 34859574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and outcomes of heart transplantation in adults with congenital heart disease.
    Alsoufi B; Kozik D; Perrotta M; Wilkens S; Lambert AN; Deshpande S; Slaughter M; Trivedi J
    Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38447194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation in the U.S.
    Alshawabkeh LI; Hu N; Carter KD; Opotowsky AR; Light-McGroary K; Cavanaugh JE; Bartlett HL
    J Am Coll Cardiol; 2016 Aug; 68(9):908-17. PubMed ID: 27561764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices.
    Gelow JM; Song HK; Weiss JB; Mudd JO; Broberg CS
    J Heart Lung Transplant; 2013 Nov; 32(11):1059-64. PubMed ID: 23921356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Outcomes of Heart Transplantation in Adults With Congenital Heart Disease Receiving Regionalized Care.
    Nguyen VP; Dolgner SJ; Dardas TF; Verrier ED; McMullan DM; Krieger EV
    J Am Coll Cardiol; 2019 Dec; 74(23):2908-2918. PubMed ID: 31806135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases.
    Rali AS; Ranka S; Mazurek JA; Brinkley MD; Cedars A; Clark D; Do N; Lazzara GE; Punnoose L; Sandhaus E; Shah A; Taduru S; Wigger M; Zalawadiya S; Rogers J; Lindenfeld J; Schlendorf K; Menachem JN
    J Card Fail; 2022 Mar; 28(3):415-421. PubMed ID: 34670174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the 2018 change in US allocation policy on adults with congenital heart disease.
    Ashraf SF; Hess N; Seese L; Kavarana MN; Tedford RJ; Rajab TK; Kilic A
    J Heart Lung Transplant; 2022 Mar; 41(3):373-381. PubMed ID: 34906403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcomes in children awaiting heart transplantation: an experience from a National Paediatric Heart Transplantation Programme.
    Shi WY; Rouse M; Weintraub RG; Zannino D; Shipp A; d'Udekem Y; Konstantinov IE
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1711-8. PubMed ID: 26802205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system.
    Gonzalez MH; Acharya D; Lee S; Leacche M; Boeve T; Manandhar-Shrestha N; Jovinge S; Loyaga-Rendon RY
    J Heart Lung Transplant; 2021 Feb; 40(2):149-157. PubMed ID: 33277169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lung allocation score maximize survival benefit from lung transplantation?
    Russo MJ; Worku B; Iribarne A; Hong KN; Yang JA; Vigneswaran W; Sonett JR
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1270-7. PubMed ID: 21497235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision.
    Kolaitis NA; Chen H; Calabrese DR; Kumar K; Obata J; Bach C; Golden JA; Simon MA; Kukreja J; Hays SR; Leard LE; Singer JP; De Marco T
    Am J Respir Crit Care Med; 2023 Feb; 207(3):300-311. PubMed ID: 36094471
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience.
    de Perrot M; Granton JT; McRae K; Pierre AF; Singer LG; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):910-8. PubMed ID: 22306224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.
    Lietz K; Miller LW
    J Am Coll Cardiol; 2007 Sep; 50(13):1282-90. PubMed ID: 17888847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Program-specific transplant rate ratios: Association with allocation priority at listing and posttransplant outcomes.
    Wey A; Gustafson SK; Salkowski N; Pyke J; Kasiske BL; Israni AK; Snyder JJ
    Am J Transplant; 2018 Jun; 18(6):1360-1369. PubMed ID: 29397038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of heart transplantation, shortened waitlist time and preserved post-transplant survival in adults with congenital heart disease, on the new heart transplant allocation system.
    Jani M; Cook S; Huang SH; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2021 Apr; 35(4):e14205. PubMed ID: 33368608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.